Concepedia

Michael A. Letavic

MA

57

Publications

2.9K

Citations

34

H-Index

1990

Active since

Affiliations

Janssen (United States)(Current)

Johnson & Johnson (United States)

Pfizer (United States)

Janssen (Belgium)

Royal College of Surgeons in Ireland

Michael A. Letavic is an author at Janssen (United States) specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

1990–2021

57

Publications

57

Pharmacological characterization of a novel centrally permeable <scp>P2X7</scp> receptor antagonist: <scp>JNJ</scp>‐47965567

Anindya Bhattacharya, Qi Wang, Hong Ao et al. · British Journal of Pharmacology · 2013 · 191 citations · Full text

Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy

Alba Jimenez‐Pacheco, Miguel Díaz‐Hernández, Marina Arribas-Blázquez et al. · Journal of Neuroscience · 2016 · 162 citations · Full text

Histamine H3 receptor antagonists: From target identification to drug leads

Pascal Bonaventure, Michael A. Letavic, Christine Dugovic et al. · Biochemical Pharmacology · 2006 · 134 citations

, , +8

microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus

Eva M. Jiménez‐Mateos, Marina Arribas-Blázquez, Amaya Sanz‐Rodriguez et al. · Scientific Reports · 2015 · 108 citations · Full text

Enantioselective Total Synthesis of Gracilins B and C Using Catalytic Asymmetric Diels-Alder Methodology

E. J. Corey, Michael A. Letavic · Journal of the American Chemical Society · 1995 · 99 citations

, , +15

Rows per page

1–5 of 57